Executive Session

S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511

Date: Tuesday, February 9th, 2016

Time: 10:00am

Location: 430 Dirksen Senate Office Building

• S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015

• S. 1622, The FDA Device Accountability Act of 2015

• S. 2014, Next Generation Researchers Act

• S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act

• S. 849, Advancing Research for Neurological Diseases Act of 2015

• S. 2503, Preventing Superbugs and Protecting Patients Act

• S. 2511, Improving Health Information Technology

Legislation

S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015

S. 1622, The FDA Device Accountability Act of 2015

S. 2014, Next Generation Researchers Act

S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act

S. 849, Advancing Research for Neurological Diseases Act of 2015

S. 2503, Preventing Superbugs and Protecting Patients Act

S. 2511, Improving Health Information Technology

1. Any additional business for consideration.